- Home
- MPB vs MGTX Comparison
MPB vs MGTX Comparison
Compare MPB & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MPB | MGTX |
|---|---|---|
| Founded | 1868 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 738.9M | 744.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MPB | MGTX |
|---|---|---|
| Price | $32.93 | $8.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $37.00 | $23.83 |
| AVG Volume (30 Days) | 88.8K | ★ 631.8K |
| Earning Date | 01-21-2026 | 11-13-2025 |
| Dividend Yield | ★ 2.71% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.40 | N/A |
| Revenue | ★ $208,869,000.00 | $27,417,000.00 |
| Revenue This Year | $26.19 | N/A |
| Revenue Next Year | $28.25 | $619.95 |
| P/E Ratio | $13.52 | ★ N/A |
| Revenue Growth | 20.73 | ★ 96.83 |
| 52 Week Low | $22.50 | $4.55 |
| 52 Week High | $33.14 | $9.73 |
Technical Indicators
Market Signals| Indicator | MPB | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 76.85 | 43.80 |
| Support Level | $31.76 | $8.25 |
| Resistance Level | $32.62 | $9.50 |
| Average True Range (ATR) | 0.61 | 0.57 |
| MACD | 0.27 | -0.01 |
| Stochastic Oscillator | 92.40 | 20.26 |
Price Performance
Historical ComparisonAbout MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.